These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16492153)

  • 1. Use of an induced fit receptor structure in virtual screening.
    Sherman W; Beard HS; Farid R
    Chem Biol Drug Des; 2006 Jan; 67(1):83-4. PubMed ID: 16492153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel procedure for modeling ligand/receptor induced fit effects.
    Sherman W; Day T; Jacobson MP; Friesner RA; Farid R
    J Med Chem; 2006 Jan; 49(2):534-53. PubMed ID: 16420040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of high throughput virtual screening by combining shape-matching and docking methods.
    Lee HS; Choi J; Kufareva I; Abagyan R; Filikov A; Yang Y; Yoon S
    J Chem Inf Model; 2008 Mar; 48(3):489-97. PubMed ID: 18302357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated molecular mechanics based induced fit protein-ligand docking method.
    Koska J; Spassov VZ; Maynard AJ; Yan L; Austin N; Flook PK; Venkatachalam CM
    J Chem Inf Model; 2008 Oct; 48(10):1965-73. PubMed ID: 18816046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor flexibility in de novo ligand design and docking.
    Alberts IL; Todorov NP; Dean PM
    J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective handling of induced-fit motion in flexible docking.
    Mizutani MY; Takamatsu Y; Ichinose T; Nakamura K; Itai A
    Proteins; 2006 Jun; 63(4):878-91. PubMed ID: 16532451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProPose: steered virtual screening by simultaneous protein-ligand docking and ligand-ligand alignment.
    Seifert MH
    J Chem Inf Model; 2005; 45(2):449-60. PubMed ID: 15807511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore-based molecular docking to account for ligand flexibility.
    Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
    Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple active site corrections for docking and virtual screening.
    Vigers GP; Rizzi JP
    J Med Chem; 2004 Jan; 47(1):80-9. PubMed ID: 14695822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing protein flexibility in docking and its applications.
    B-Rao C; Subramanian J; Sharma SD
    Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor flexibility for large-scale in silico ligand screens: chances and challenges.
    Fischer B; Merlitz H; Wenzel W
    Methods Mol Biol; 2008; 443():353-64. PubMed ID: 18446296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
    Popov VM; Yee WA; Anderson AC
    Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors.
    Moitessier N; Therrien E; Hanessian S
    J Med Chem; 2006 Oct; 49(20):5885-94. PubMed ID: 17004704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.